Publications by authors named "U K Mehta"

Aspirin is used in patients with coronary artery disease essential in both acute and chronic phases of treatment, especially post-catheterization and post-coronary artery stent placement. Some patients have sensitivity to aspirin. Hypersensitivity reaction symptoms include itchy and watery eyes, itchy rash, worsening asthma, wheezing to fatal angioedema, and anaphylaxis.

View Article and Find Full Text PDF
Article Synopsis
  • The study compared the Roussel Uclaf Causality Assessment Method (RUCAM) with a multidisciplinary expert panel to assess drug-induced liver injury (DILI) from antituberculosis and antiretroviral therapies.
  • It involved 48 participants, all of whom were people with HIV, with many on multiple potentially harmful medications, which made it challenging to identify the exact cause of liver injury.
  • The results showed that the RUCAM had low sensitivity (7%) but high specificity (100%) in identifying probable or certain drug causes of liver injury, indicating it isn't very reliable in this context compared to the expert panel.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated how COVID-19 disruptions affected neuroscience research projects and young researchers in India through an online survey targeting medical trainees, post-docs, PhD students, and early career faculty.
  • A total of 504 valid responses revealed that over 83% of participants experienced negative impacts on their research, with one-third noting delays and many adapting their methodologies due to the pandemic.
  • The findings highlighted significant challenges, particularly for those involved in prospective studies, emphasizing the need for focused support for neuroscience research in the post-pandemic landscape.
View Article and Find Full Text PDF

We aimed to assess the incremental value of schizophrenia polygenic risk score (PgRS) and resting-state functional brain connectivity (rsFC) when added to clinical data in predicting the six-week response to oral risperidone (Risperdal) in schizophrenia. Fifty-seven, 54, and 43 individuals in a group of never-before-treated first-episode schizophrenia had good quality whole-genome sequencing (10x), rsFC, and both genomic and rsFC data, respectively, at baseline. Symptom severity ratings were obtained at baseline and six-weeks of oral risperidone (Risperdal) treatment.

View Article and Find Full Text PDF